Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,201 to 1,220 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01HL122068 | Targeting beta-arrestins in Pulmonary Fibrosis | 1 | 2018 |
| R01HL122157 | TRPM2 mediates neutrophil transendothelial migration and inflammation | 1 | 2018 |
| R01HL124018 | Novel platelet functions for in T-cell helper cell responses | 1 | 2018 |
| R01HL125350 | Repair mechanisms of sepsis induced endothelial dysfunction and lung injury | 1 | 2018 |
| R01HL125863 | Toward Diagnostics and Therapies of Molecular Subcategories of CAD | 1 | 2018 |
| R01HL126186 | Pluripotent cell-derived exosomes as mediators of myocardial regeneration | 1 | 2018 |
| R01HL127151 | Thrombo-Inflammatory Role of CD39 In Vascular Stasis | 1 | 2018 |
| R01HL128359 | Endothelial Cell Deubiquitinase A20 Signals Repair of Lung Vascular Injury | 1 | 2018 |
| R01MH086633 | Statistical Analysis of Biomedical Imaging Data in Curved Space | 1 | 2018 |
| R01MH105128 | Circuitry mechanisms underlying normal and aberrant adult hippocampal neurogenesis | 1 | 2018 |
| R01NS085336 | Pediatric low-grade gliomas: biology and molecular targeting. | 1 | 2018 |
| R01NS087913 | Metabolism Informs Intertumoral & Intratumoral Heterogeneity | 1 | 2018 |
| R21AI127354 | Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple Sclerosis | 1 | 2018 |
| R21AI129303 | Mechanisms of sexual Zika virus transmission and early immunopathogenesis | 1 | 2018 |
| R21AI129369 | Rapid Phenotyping of the ZIKV Genome | 1 | 2018 |
| R21DC016732 | Zika Virus Cell Tropism and Pathogenesis in the Developing Inner Ear | 1 | 2018 |
| R21ES028124 | Impact of endocrine disruptors on the human sperm methylome: a risk factor for autism? | 1 | 2018 |
| R21NS105837 | Engineering a 3D human neurovascular unit for investigating and countering neuroinflammatory mechanisms of HIV | 1 | 2018 |
| R33CA202820 | Clinical implementation of single cell tumor transcriptome analysis | 1 | 2018 |
| R33HL120757 | Identification of causal coronary heart disease variation in smooth muscle cells | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=61